Christmas 2024 & New Year 2025 opening hours
Confirming our dispatch and office closure dates during the festive season
COVID-19: Research & Candidates for Therapy
Here we list the products that are currently being investigated for effectiveness against COVID-19
16 Mars 2020
COVID-19: Research & Candidates for Therapy
There are a number of research products supplied by Glentham Life Sciences that are thought to have therapeutic potential against COVID-19, or could help to limit further spread of the SARS-CoV-2 virus.
The following products are all listed and sold by Glentham for research purposes, and can be delivered next-day across Europe and North America:
GP4306 - Camostat mesylate (59721-29-8)
GA7477 - Chloroquine diphosphate salt (50-63-5)
GP6351 - Lopinavir (192725-17-0)
GP1071 - Remdesivir (1809249-37-3)
GA5462 - Ribavirin (36791-04-5)
GP3714 - Ritonavir (155213-67-5)
We will continue to update this list as more potential candidates are highlighted to us.
Last updated: 16/03/20
Upcoming Exhibition: Medica 2023
Come and meet the Glentham Life Sciences team at Medica in Düsseldorf, which runs from 13th to 16th November 2023.
Announcing our subsidiary for the EU, Glentham Life Sciences GmbH
We are excited to announce that Glentham Life Sciences GmbH has been established in Germany
Cookies
Nous utilisons une série de cookies afin de vous offrir la meilleure expérience de navigation possible. Il s'agit de cookies essentiels au fonctionnement du site web, tels que les cookies utilisés par le panier d'achat, ainsi que de cookies non essentiels utilisés uniquement à des fins statistiques anonymes. En cliquant sur Accepter, vous autorisez tous les cookies et toutes les fonctionnalités du site web. Si vous cliquez sur Refuser, vous n'autoriserez que les cookies essentiels, mais certaines fonctionnalités du site web pourraient en être affectées.